Ligand ID: CIL


Drugbank ID:
DB01597
(Cilastatin)


Indication:
Combined intravenously with imipenem in order to protect it from dehydropeptidase and prolong its antibacterial effect.

Get human targets for CIL in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'CIL' AND SARS-COV-2 / COVID-19 STRUCTURES

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ITU_A_CILA451_1
(RENAL DIPEPTIDASE)		6w02 NSP3
(SARS-CoV-2)		5 / 12
ASP B  66
HIS B  94
HIS B  45
ASN B  40
PRO B  74
1.75A23.55
None
None
None
APR  B 201 (-3.8A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ITU_B_CILB452_1
(RENAL DIPEPTIDASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 12
ASP A 291
HIS A 309
TYR A 238
ASP A 235
VAL A 234
1.79A17.49
None